-
Jio Platforms
1,380.50 1,356.40(%) -
Reliance Industries
1,182.00 1,611.20(%) -
PTC Industries
24,750.00 26,049.95(%) -
NSE
1,795.00 1,878.00(%) -
Dalmia BharatLtd
1,403.50 1,464.85(%) -
Aeroflex
579.00 613.50(%) -
Pidilite Inds.
1,429.05 1,707.95(%) -
The Bombay Burmah
1,176.50 1,108.20(%) -
Billionbrains
189.10 112.02(%) -
Cholaman.Inv.&Fn
1,589.95 1,952.00(%) -
Bajaj Finance
932.45 1,177.60(%) -
Birlasoft Ltd
351.80 473.75(%) -
Max Healthcare
865.95 1,196.50(%) -
M & M Fin. Serv.
256.60 253.30(%) -
Adani Ports
1,857.35 1,891.80(%) -
Coromandel Inter
1,734.65 2,496.10(%) -
Tube Investments
2,098.60 2,006.00(%) -
JSW Dulux
286.50 374.67(%) -
Acutaas Chemical
4,000.00 3,977.00(%) -
Moneyview
52.44 65.43(%)
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
- Overview
- Key Ratios
- Financials
- Shareholding
- Company Info
- Peer Comparison
Tatva Chintan Pharma Chem Ltd Chemicals
- Indian Private
- BSE Code : 75545.0
- ISIN : INE0GK401011
-
Today’s Low
1,591.00 -
Today’s High
1,660.00
-
Open
1,614.00 -
Perv Close
1,605.40 -
52W Low
1,044.10 -
52W High
2,113.60
Key Indicators
-
P/E(TTM)
73.18
-
Mar.Cap (₹Cr.)
3,807.76
-
Div & Yield %
0.12
-
Book Value(₹)
333.22
-
Debt-Equity Ratio
1.40
-
AGM Date
28-Oct-2026
-
EPS
22.15
-
P/E Ratio
73.18
Financials Ratios
-
Debt-Equity Ratio
0.15
-
Mar.Cap (₹Cr.)
3,807.76
-
RONW (%)
4.85
-
ROCE (%)
6.99
Score Board
-
Equity (₹ in Cr.)
23.39
-
BV (₹)
333.20
-
Sales( ₹ in Cr.)
496.30
-
NP (in Cr.)
39.12
-
NP Var(%)
10842.0
-
Div%
20.0
-
CPS (₹)
32.50
-
EPS (₹)
16.70
-
Traded Value (₹ in Lakhs)
3,791.85
-
52 Week High
2,113.60
-
52 Week Low
1,044.10
-
Price BSE
1621.0
-
Price NSE
1,628.00
-
Market Capital( in Cr.)
3,791.85
-
P/C Ratio
49.90
-
P/E Ratio
96.90
-
Price Vs.BV
16.70
-
21-Oct-2026( 11:04)
Results - Announcements - Tatva... - <p>Tatva Chintan Pharma Chem L...
-
19-Oct-2026( 07:00)
Results - Announcements - Tatva... - <p>Tatva Chintan Pharma Chem L...
-
12-Oct-2026( 12:31)
Corporate News - Tatva... - <p>Tatva Chintan Pharma Chem L...
-
06-Oct-2026( 01:13)
Corporate News - Tatva... - <p>Tatva Chintan Pharma Chem L...
Navigate The Market With Confidence
Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions
Financials
All Values are in (₹Cr)| Particulars(INCOME) | 2026 Mar | 2025 Mar | 2024 Mar | 2023 Mar | 2022 Mar | 2021 Mar |
|---|---|---|---|---|---|---|
| INCOME : | ||||||
| Sales Turnover | 496.30 | 366.42 | 378.68 | 403.04 | 427.81 | 291.19 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 496.30 | 366.42 | 378.68 | 403.04 | 427.81 | 291.19 |
| Other Income | 3.53 | 3.56 | 7.51 | 5.68 | 10.63 | 5.10 |
| Stock Adjustments | 31.79 | -23.90 | 10.72 | -6.51 | 58.04 | 5.20 |
| Total Income | 531.62 | 346.08 | 396.91 | 402.21 | 496.48 | 301.49 |
| EXPENDITURE : | ||||||
| Raw Materials | 262.75 | 173.76 | 178.76 | 215.82 | 254.49 | 153.53 |
| Power and Fuel Cost | 44.84 | 34.44 | 34.78 | 23.61 | 22.62 | 9.92 |
| Employee Cost | 62.93 | 52.92 | 54.76 | 41.21 | 30.82 | 23.80 |
| Other Manufacturing Expenses | 24.95 | 17.57 | 19.59 | 18.03 | 23.95 | 16.45 |
| Selling and Administration Expenses | 42.50 | 36.43 | 32.62 | 38.63 | 46.95 | 26.53 |
| Miscellaneous Expenses | 0.64 | 1.39 | 1.88 | 8.01 | 1.01 | 0.76 |
| Employee Benefit Expenses | 62.93 | 52.92 | 54.76 | 41.21 | 30.82 | 23.80 |
| Less: Preoperative Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Expenses | 438.60 | 316.51 | 322.38 | 345.31 | 379.85 | 231.00 |
| Operating Profit | 93.02 | 29.57 | 74.53 | 56.91 | 116.64 | 70.49 |
| Interest | 3.01 | 1.45 | 6.66 | 8.52 | 5.19 | 4.41 |
| Gross Profit | 90.01 | 28.12 | 67.87 | 48.39 | 111.45 | 66.08 |
| Depreciation | 36.84 | 27.65 | 25.60 | 9.55 | 8.18 | 6.73 |
| Profit Before Tax | 53.17 | 0.47 | 42.27 | 38.84 | 103.27 | 59.35 |
| Current Tax | 10.07 | 0.00 | 7.34 | -2.80 | 18.01 | 10.43 |
| Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | 4.02 | 0.13 | 5.57 | 1.17 | -10.73 | -2.44 |
| Reported Net Profit | 39.08 | 0.33 | 29.35 | 40.47 | 95.99 | 51.36 |
| Extraordinary Items | -0.04 | -0.03 | -0.08 | -3.31 | -0.04 | -0.03 |
| Adjusted Net Profit | 39.12 | 0.36 | 29.43 | 43.78 | 96.03 | 51.39 |
| Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -12.05 |
| P & L Balance brought forward | 294.23 | 298.58 | 273.91 | 237.88 | 141.89 | 106.61 |
| Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Appropriations | 2.34 | 4.68 | 4.68 | 4.43 | 0.00 | 4.02 |
| P & L Balance carried down | 330.97 | 294.23 | 298.58 | 273.91 | 237.88 | 141.89 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity Dividend (%) | 20.00 | 10.00 | 20.00 | 20.00 | 20.00 | 50.00 |
| Dividend Per Share(Rs) | 2.00 | 1.00 | 2.00 | 2.00 | 2.00 | 5.00 |
| Earnings Per Share-Unit Curr | 16.71 | 0.14 | 12.55 | 18.26 | 43.31 | 25.57 |
| Earnings Per Share(Adj)-Unit Curr | 16.71 | 0.14 | 12.55 | 18.26 | 43.31 | - |
| Book Value | 324.14 | 308.36 | 310.31 | 227.74 | 211.54 | 80.61 |
| Book Value(Adj)-Unit Curr | 324.14 | 308.36 | 310.31 | 227.74 | 211.54 | - |
